Clinical Trial Update: Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature [Phase 3]

View source ↗

Summary

This document discusses an ongoing Phase 3 trial evaluating the efficacy and safety of oral potassium citrate to prevent nephrocalcinosis in extremely premature…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrocalcinosis

Drugs mentioned

• POTASSIUM CITRATE (Potassium citrate)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: Nephrocalcinosis | Phase 3 | Status: UNKNOWN